Michael Boyiadzis
Pittsburgh, PANPI 1255303343
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $100 of the $143 with a category attached, or 69.7%. Janssen Research & Development, LLC accounts for 69.7% of it on its own, with 1 other manufacturer making up the rest.
Across 2 payments — averaging $71.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$100
- Servier Pharmaceuticals LLC$43
Across 50 payments — averaging $21,964 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$676K
- Merck$266K
- Astellas Pharma Global Development$123K
- Boehringer Ingelheim International GmbH$34K
- AbbVie$50
What the payments were for
- Speaking & faculty fees$4330%
- Food & beverage$10070%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 1 | $100 |
| Servier Pharmaceuticals LLC | 1 | $43 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.